| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006083003A1 Novel benzamidine compound |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082872A1 1-(piperidin-4-yl)-1h-indole derivative |
| 08/10/2006 | WO2006082834A1 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 08/10/2006 | WO2006082511A1 Novel salt form of a dopamine agonist |
| 08/10/2006 | WO2006082412A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | WO2006082404A1 Compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082392A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082185A1 Novel 6-pyridylphenanthridines |
| 08/10/2006 | WO2006082002A1 Imidazole derivatives |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006070208A8 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists |
| 08/10/2006 | WO2006069208A3 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 08/10/2006 | WO2006066778A3 Novel heteroarylacetamides |
| 08/10/2006 | WO2006044602A3 Diphenyl substituted alkanes as flap inhiibitors |
| 08/10/2006 | WO2006040465A3 Novel product, method and intermediates for the preparation of azetidine derivatives |
| 08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
| 08/10/2006 | WO2005047279A8 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/10/2006 | US20060178516 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178490 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 08/10/2006 | US20060178419 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178416 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/10/2006 | US20060178415 Azole derivatives as antifungal agents |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178406 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 08/10/2006 | US20060178397 1-(3-Methyl-isoquinolin-5-yl)-3-[1-(2-trifluoromethyl-benzyl)pyrrolidin-3-yl]urea; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, algesia, neuralgia, dental pain, headache, migraine, neuropathies, carpal tunnel syndrome, diabetic neuropathy |
| 08/10/2006 | US20060178382 Chinazoline derivatives as aurora kinase inhibitors |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178370 Ketopiperazine derivatives as bradykinin antagonists |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178363 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/10/2006 | CA2597134A1 Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596854A1 Imidazole derivatives |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2595834A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | CA2595801A1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | CA2595252A1 Novel 6-pyridylphenanthridines |
| 08/10/2006 | CA2594466A1 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 08/10/2006 | CA2593857A1 Amino-pyridines as inhibitors of .beta.-secretase |
| 08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687452A2 Human hinge core mimetibodies, compositions, methods and uses |
| 08/09/2006 | EP1687299A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar |
| 08/09/2006 | EP1687298A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 08/09/2006 | EP1687295A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 08/09/2006 | EP1687294A2 Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 08/09/2006 | EP1687293A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1687286A1 Developments in biologically active methylene blue derivatives (2) |
| 08/09/2006 | EP1687280A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1687004A2 Pyridine compounds |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686999A1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1560822B1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 08/09/2006 | EP1483245B1 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1227859B1 Neurophilin ligands for treating ocular conditions |
| 08/09/2006 | EP1185267B1 Dermal anesthetic agents |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816542A 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 08/09/2006 | CN1816541A Substituted-1-phthalazinamines as vr-1 antagonists |
| 08/09/2006 | CN1816529A Pyrazole-amide compounds useful as kinase inhibitors |
| 08/09/2006 | CN1816527A Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin |
| 08/09/2006 | CN1816526A In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent |
| 08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/08/2006 | US7087764 Reacting 2,5-disubstituted-phenylalkylsulfide compound with halogenating agent to produce 2,5-disubstituted-phenylsulfenylhalide compound |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087757 Phenyl-substituted imidazopyridines |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087638 Plant safening agents; |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |